Medicines Optimisation
Hello [subscriber:firstname | default:reader].

Supply Issues & Shortages - DHSC and NHSE&I Guide

The DHSC and NHSE&I jointly published a Guide to Managing Medicines Supply and Shortages in November 2019. The guide sets out the approach taken by the DHSC Medicines Supply Team and NHS&I Commercial Medicines Unit, with information on: intelligence; information gathering; risk assessment; categorisation; escalation routes; management options and communication methods. The DHSC and NHSE&I teams and the multi-disciplinary pan-system …

Read more

COVID-19 - OTC Painkiller Demand Surge

Amid news reports of panic buying of paracetamol, the Executive Director of the Healthcare Distribution Association — the membership organisation for UK wholesalers —  has told the Pharmaceutical Journal that there are currently no medicines shortages in the UK. Adding that: “There may be cases where deliveries into pharmacies may not be the amount they ordered because they are ordering a lot …

Read more

COVID-19 - UK Pharmaceutical Industry Response

The Association of the British Pharmaceutical Industry have today launched a 'Responding to COVID-19' webpage, with information about the potential impact of the pandemic on the medicines supply chain and the steps being taken to safeguard supplies, including: The UK Government has asked pharmaceutical companies where possible to retain any remaining additional stockpiles of medicines that were built in preparation …

Read more

COVID-19 + ACE-Is or ARBs - European Society of Cardiology Position Statement

There has been speculation in medical journals, online discussion forums and elsewhere about a possible link between treatment with ACE-inhibitors or Angiotensin Receptor Blockers and more severe consequences of COVID-19 infection. The European Society of Cardiology have reviewed the evidence and issued the following statement: The Council on Hypertension of the European Society of Cardiology wish to highlight the lack of any evidence supporting …

Read more

COVID-19 - NHSEI Prescription Advice

The NHS England and Improvement Medical Director for Primary Care, Dr Nikita Kanani, has issued a COVID-19 update to General Practices. The letter (available from the primary care page of the NHSE&I Coronavirus Guidance for Clinicians collection) includes the following important advice about prescriptions: Practices should not change their repeat prescription durations or support patients trying to stockpile: these actions …

Read more

Inhaler Prescribing - Carbon Footprint

The asthma inhaler patient decision aid published by NICE last year includes important information about the different carbon footprints of available devices - and highlights the fact that a typical metered dose aerosol inhaler (MDI) has a carbon footprint that is roughly TWENTY-FIVE times as big as that of a typical dry powder inhaler. The annual carbon footprint of primary care …

Read more

Integrated Yellow Card Reporting - 93% GP coverage

The MHRA & EMIS have announced the roll-out of integrated reporting of suspected adverse drug reactions (ADRs) to the Yellow Card Scheme via EMIS Web, covering approximately 4000 GP practices. Reporting guidance for EMIS Web users can be found on EMIS Now. Integrated reporting is already in place with SystmOne and Vision. The development with EMIS Web means that integrated …

Read more